Anti-TNFRSF5/CD40 Antibody (Mitazalimab)
Catalog No.
F1061
Anti-TNFRSF5/CD40 Antibody (Mitazalimab)
Featured Products
Mitazalimab (ADC-1013; JNJ-64457107) is an FcγR-dependent CD40 agonist with tumor-directed activity. Mitazalimab activates antigen-presenting cells, such as dendritic cells (DCs), to prime tumor-reactive T cells. As a result, Mitazalimab induces tumor-specific T cell infiltration and tumor killing. Mitazalimab reshapes the tumor-infiltrating bone marrow microenvironment.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
143.44 kDa
Dry ice
2055640-86-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
ADC 1013, JNJ-64457107
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P25942
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFRSF5 / CD40
Please avoid freeze-thaw cycles.